Pulsed-Field Ablation System Approved by FDA for Patients With Paroxysmal Atrial Fibrillation

The U.S. Food and Drug Administration (FDA) has approved Boston Scientific’s pulsed-field ablation system for the treatment of patients with refractory, recurrent, symptomatic paroxysmal atrial fibrillation.